CSF2 and neoplasm: A recently reported oncolytic vaccinia virus armed with GM-CSF and a PD-L1 inhibitor resulted in enhanced DC infiltration and maturation in the tumour, which activated endogenous T cell responses against dominant and subdominant tumour neoantigens.